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“A human being is a part of the whole called by us universe, a part limited in time and 
space. He experiences himself, his thoughts and feelings as something separated from the 
rest, a kind of optical delusion of his consciousness. This delusion is a kind of prison for 
us, restricting us to our personal desires and to affection for a few persons nearest to us. 
Our task must be to free ourselves from this prison by widening our circle of compassion 
to embrace all living creatures and the whole of nature in its beauty."  
Albert Einstein 
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Abstract 
Neurodegenerative diseases, such as Parkinson’s Disease or Alzheimer’s Disease, are 
characterized by the death of a subset of neurons over long periods of time. These age-
related diseases are becoming more prevalent with the generalized increase of life 
expectancy and have been linked by many authors with increased oxidative stress levels. 
Indeed, oxidative stress effects can be accounted as cumulative damage, which associates 
well with the delayed onset and progressive nature of these conditions. Moreover, various 
results on life extension research strongly support the hypothesis that enhancing the cell 
protective systems against oxidative stress can extend life span. In view of this, the 
present study aimed at evaluating the role of the antioxidant α-tocopherol (vitamin E) on 
induced oxidative stress conditions. α-tocopherol (vitamin E) was chosen for its principal 
role in scavenging lipid peroxyl radicals, at lipoproteins and cell membranes, hence 
breaking the chain of lipid peroxidation initiated by ROS. 
The toxic effect of hydrogen peroxide (H2O2) and the antioxidant role of vitamin E were 
investigated using Saccharomyces cerevisiae as a model for cell viability. A High-
Performance Liquid Chromatography analysis was also performed to assess 3-
nitrotyrosine and GSH:GSSG production levels, due to their relevance as oxidative stress 
biomarkers. 
Altogether, the results presented here demonstrated that H2O2 exposure decreased yeast 
cells viability equally, independent of dose, and that the adverse effects were, at least, 
partially rescued by the combined exposure with vitamin E. The results from redox 
biomarkers were, however, shown to be inconclusive.  
This preliminary study helped to understand the dual nature of vitamin E, under the 
conditions tested. However, future studies should be able to further explore vitamin E 
antioxidant role in pathological models of neurodegenerative diseases. 
 
Key words: neurodegenerative diseases, oxidative stress, Saccharomyces cerevisiae, α-
tocopherol, vitamin E. 
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Resumo 
As doenças neurodegenerativas, tais como Parkinson ou Alzheimer, caracterizam-se pela 
morte de um conjunto de neurónios durante um longo período de tempo. Estas doenças 
associadas com a idade estão a tornar-se cada vez mais prevalentes na população com o 
aumento da esperança média de vida, e têm sido associadas, por muitos autores, com 
níveis aumentados de stress oxidativo. De facto, os efeitos do stress oxidativo podem ser 
considerados como danos cumulativos, o que se correlaciona bem com o início tardio e a 
natureza progressiva destas doenças. Além disso, vários resultados de estudos sobre a 
extensão do tempo de vida apoiam fortemente a hipótese de que o melhoramento dos 
sistemas de proteção celular contra o stress oxidativo pode efetivamente prolongar o 
tempo de vida. Neste contexto, o presente estudo teve como objetivo avaliar o papel do 
antioxidante α-tocoferol (vitamina E) em condições de stress oxidativo induzido. O α-
tocoferol (vitamina E) foi escolhido pelo seu importante papel de remoção de radicais 
peroxil lipídicos, nas lipoproteínas e membranas celulares, interrompendo a cadeia de 
peroxidação lipídica iniciada pelas espécies reativas de oxigénio (EROs). 
O efeito tóxico do peróxido de hidrogénio (H2O2) e o papel antioxidante da vitamina E 
foram investigados usando Saccharomyces cerevisiae como modelo para a viabilidade 
celular. Uma análise por Cromatografia Líquida de Alta Eficiência foi também realizada, 
de forma a se avaliar os níveis de produção de 3-nitrotirosina e o rácio de GSH:GSSG, 
dada a sua relevância enquanto biomarcadores de stress oxidativo. 
Em conjunto, os resultados aqui apresentados demonstraram que a exposição ao H2O2 
diminuiu a viabilidade das células de levedura, independentemente das concentrações 
testadas, e que os efeitos adversos foram, pelo menos parcialmente, recuperados pela 
exposição combinada com vitamina E. Os resultados dos biomarcadores de oxidação-
redução foram, no entanto, inconclusivos. 
Este estudo preliminar ajudou a compreender a natureza dual da vitamina E, sob as 
condições testadas. No entanto, estudos futuros devem ser capazes de explorar ainda mais 
o papel antioxidante da vitamina E em modelos patológicos de doenças 
neurodegenerativas. 
Palavras-chave: doenças neurodegenerativas, stress oxidativo, Saccharomyces 
cerevisiae, α-tocopherol, vitamin E. 
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1 | Oxidative Stress 
The sequential reduction of molecular oxygen through the addition of electrons leads to 
the formation of a number of intermediate partially reduced oxygen species, with one or 
more unpaired electrons, collectively termed reactive oxygen species (ROS) (Chiurchiù, 
Orlacchio, & Maccarrone, 2016; Riley, 2009). In homeostatic cells of aerobic organisms, 
the generation of ROS is well controlled by various antioxidant molecules and enzymes, 
with ROS performing important functions throughout the organism, from defense against 
external agents to intracellular and external signaling. For example, it has been reported 
that ROS regulate cellular growth and apoptosis, as well as blood pressure, cognitive 
function and immune function (Di Meo, Reed, Venditti, & Victor, 2016). However, when 
ROS levels exceed the antioxidant capacity of a cell, it enters a stress oxidative state. If 
the cell cannot revert this redox unbalance, destruction of cellular components through 
structural modification will occur (lipids, proteins, sugars and nucleic acids) and the cell 
will ultimately die (Chiurchiù et al., 2016; Coyle & Puttfarcken, 2016; Gagné, 2014; 
Klein & Ackerman, 2003). The main ROS molecules are presented in Table I. 
Table I: Main ROS molecules, radicals and non-radicals. 
Radicals Non-radicals 
Formula Name Formula Name 
O2
•‒ Superoxide H2O2 Hydrogen peroxide 
HO• Hydroxyl HOCl‒ Hypochlorous acid 
ROO• Peroxyl O3 Ozone 
RO• Alkokyl 1O2 Singlet oxygen 
HO2
• Hydroperoxyl ONOO‒ Peroxynitrite 
 
The generation of ROS under physiological conditions occurs as a natural by-product of 
aerobic metabolism. Indeed, the majority of ROS produced in cells arises from the 
mitochondrial respiratory chain; it is estimated that 1% to 3% of the total oxygen taken 
up by mitochondria during ATP production is incompletely reduced to H2O, giving rise 
to the short-lived superoxide anion (O2
•-) by side reactions of complex I and III (Turrens, 
1997). O2
•- is then dismuted to H2O2 either spontaneously or by superoxide dismutase 
(SOD), an important antioxidant enzyme defense. Despite being a less potent oxidant 
than O2
•-, H2O2 can diffuse across membranes, throughout the cell, and generate the 
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hazardous hydroxyl radicals (HO•) in the presence of iron via the Fenton reaction 
(reaction 1) (Filomeni, Aquilano, & Ciriolo, 2008; Huseby, Sundkvist, & Svineng, 2008; 
Riley, 2009; Weissbach & Brot, 2008). Hydroxyl radicals species are the most reactive 
of ROS and, therefore, the most damaging (Riley, 2009).  
(1) H2O2 + Fe2+ → OH• + OH− + Fe3+   
The reactivity of ROS with the signaling molecule nitric oxide (NO•) leads to the 
formation of many other reactive species, termed reactive nitrogen species (RNS), which 
also include the potent oxidant molecule peroxynitrite (ONOO−). This reactive species is 
produced by the combined reaction of O2
•₋ with NO• (Chiurchiù et al., 2016; Di Meo et al., 
2016; Patel et al., 1999).  
Alongside hydroxyl radicals, peroxynitrite is also able to cause serious damage to 
mithocondria, by diffusing through the its compartments and undergoing fast reactions 
that result in oxidation, nitration (addition of NO2), and nitrosation (addition of NO) of 
critical components in the matrix, inner and outer membrane, and intermembrane space. 
As the respiratory chain loses efficiency, more ROS and RNS are formed causing more 
damage to the mitochondria. Extensive mitochondria damage leads ultimately to cell 
death by apoptosis (Weissbach & Brot, 2008); this is observed in different 
pathophysiological conditions, including main neurodegenerative diseases (Di Meo et al., 
2016; Radi, Cassina, Hodara, Quijano, & Castro, 2002; Sarti et al., 2012). Indeed, the 
oxidising potential of ONOO- is sufficient to directly initiate lipid peroxidation reactions 
which results in the formation of nitrated lipids. The lipoproteins are particularly 
interesting targets for ONOO- as they contain a mixture of amino acids and unsaturated 
lipids. Hence, the reaction between RNS and fatty acids can result in the formation of 
both oxidised lipids as well as nitrated lipid species. Another important deleterious effect 
of ONOO‒ is the inactivation of enzymes through disruption of their iron-sulphur centres. 
(Patel et al., 1999). The main RNS molecules are presented in Table II. 
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Table II: Main RNS molecules, radicals and non-radicals 
 
Even though mitochondria is the predominant source of ROS in all cell types (Marrocco, 
Altieri, & Peluso, 2017), reactive species are also generated from the metabolism of 
xenobiotics and from enzyme systems, such NADPH oxidase, as part of the host defense 
mechanisms and as signalling molecules. Radiation and atmospheric pollutants are also 
considered exogenous sources of ROS (Huseby et al., 2008).  
However, there are other sites of ROS production worth mentioning, given their 
importance for cellular homeostasis and association with oxidative stress under 
pathological conditions. Peroxisomes, the organelles that carry out oxidation reactions, 
generating H2O2, are unable to prevent the release of about 20-60% of the H2O2 generated 
inside, despite the high content of catalase (CAT) and other antioxidants. This 
phenomenon is believed to be enhanced under pathological conditions (Di Meo et al., 
2016). Moreover, abnormalities in the endoplasmic reticulum (ER), which is involved in 
multiple functions, are highly associated with oxidative stress. The protein folding 
process (which is dependent on redox homeostasis) can get disrupted and enhance the 
production of misfolded proteins, consequently causing further stress (Di Meo et al., 
2016; Huseby et al., 2008; Malhotra & Kaufman, 2007). In addition, the attack of free 
radicals to lipid membranes, especially polyunsaturated fatty acids (PUFAs), also 
produces lipid radicals, which are capable of oxidizing other lipids, in a chain reaction 
manner. This process is termed lipid peroxidation and can cause serious damage if the 
antioxidant systems present are not enough to scavenge the free radicals and stop the 
oxidative chain reaction (Ayala, Muñoz, & Argüelles, 2014; Di Meo et al., 2016). Thus, 
dysfunctional problems affecting these processes reportedly contribute to a greater 
production of reactive species which, in turn, increases cell dysfunction as well as ROS 
levels, in a cyclic way.  
Radicals Non-radicals 
Formula Name Formula Name 
NO• Nitric oxide ONOO‒ Peroxynitrite 
NO2
• Nitrogen dioxide N2O3 Dinitrogen trioxide  
 ONOOH Peroxynitrous acid 
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2 | Cellular defences against reactive species 
Because of the potential damage that can be engendered by reactive species, aerobic 
organisms have integrated antioxidant systems, which include enzymatic and non-
enzymatic antioxidants, usually effective in neutralizing free radicals or their harmful 
effects, thus maintaining the redox homeostasis (Birben et al., 2012). Naturally occuring 
antioxidants are mainly enzymes such as superoxide dismutases (Mn-SOD in 
mitochondria and Cu-Zn-SOD in the cytosol), catalase (CAT), glutathione 
peroxidase/reductase (GPx/GR), thioredoxins, glutaredoxins and peroxiredoxin. Non-
enzymatic antioxidant molecules occurring naturally are glutathione (GSH), uric acid, 
pyruvate or amino acids (cysteine and methionine). In addition, antioxidant molecules 
can also be acquired by diet, they can be lipid-soluble antioxidants, such as α-tocopherol 
(Vitamin E), carotenoids, quinones, as well as water-soluble antioxidants, such as 
ascorbic acid (Vitamin C) and some other polyphenols. These compounds act by trapping 
secondary oxygen radicals, such as peroxyl radicals, being themselves converted to stable 
free radicals in the process (Chiurchiù et al., 2016; Temple, Perrone, & Dawes, 2005). 
Another cytoprotective mechanism is the sequestering  of transition metals ions (eg., Fe+2, 
Cu+2) in their inactive form (e.g. ferritin, ceruloplasmin) so that the cell is able to control 
its distribution and avoid potential damage (Di Meo et al., 2016; Repetto, Ferrarotti, & 
Boveris, 2010). Mechanisms have also evolved to repair and remove damaged material, 
which is the case of chaperones, proteasomes, lysosomes, proteases, phospholipases and 
DNA repair enzymes (Davies, 2016; Di Meo et al., 2016). 
3 |Biological Effects of Oxidative Stress 
3.1 Lipid peroxidation 
Lipid peroxidation is the main molecular mechanism involved in the oxidative damage to 
cell structures and in the toxicity process that leads to cell death (Barrera, Pizzimenti, & 
Dianzani, 2008). In this process, that affects cellular membranes, lipoproteins, and other 
molecules containing lipids, ROS/RNS promote the abstraction of a hydrogen or the 
addition of an oxygen radical in unsaturated lipids, especially polyunsaturated fatty acids 
(PUFAs). This leads to an oxidative cascade that generates more lipid radicals and other 
highly reactive products (Ayala et al., 2014). Moreover, lipid peroxidation is catalysed 
by transition metals that not only promote free radicals by dismuting H2O2 into HO•, but 
also alter the physical properties of the bilayer when they bind to the negatively charged 
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phospholipids, which also favours lipid peroxidation. Considering that the central nervous 
system (CNS) has a high consumption of oxygen (about 20–30%), high levels of 
polyunsaturated fatty acids (PUFAs), and high levels of redox transition metals, it is 
particularly susceptible to oxidative stress (Leng et al., 2015; Repetto et al., 2010; M. 
Repetto, Semprine, & Boveris, 2012). The overall process of lipid peroxidation consists 
of three steps: initiation, propagation, and termination, which are described below (Bowry 
& Stocker, 1993; Josephy & Mannervik, 2006; Sachdeva, Karan, Singh, & Dhingra, 
2014). 
Initiation: 
The lipid peroxidation is initiated, when any free radical (usually OH•) attacks and 
removes a hydrogen atom (H) from a fatty acid molecule (LH). This attack easily 
generates free radicals from PUFAs. A fatty acid radical is formed (L•): 
Propagation phase: 
In the propagation phase, the fatty acid radical (L•) takes up oxygen to form a lipid peroxyl 
radical (LOO•). The latter, in turn, can remove H• from another fatty acid (LH) to form a 
lipid hydroperoxide (LOOH) and another L• that continues the chain reaction. 
In the presence of transition metal ions, the lipid hydroperoxides are capable of further 
stimulating lipid peroxidation, generating lipid oxyl (LO•) and lipid peroxyl (LOO•) 
radicals: 
Many aldehydes are produced during this phase and although highly stable when 
compared with free radicals, they can attack targets outside the cell, far from the site of 
their production, causing oxidative stress, oxidative damage and apoptosis (Repetto et al., 
2012).  
Termination: 
• LOO• + LH →  LOOH + L•  
• L• + O2 →  LOO•  
• 2 LOOH →  LO• + LO2• + H2O 
• LH + OH•  →  L• + H2O  
• LOOH →  LO• + LOO• + aldehydes 
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Lipid peroxidation terminates when any two free radicals combine to form non-radical 
products. These are non-initiating and non-propagating species.   
 
The chain reaction can also be broken by the action of antioxidants such as vitamin E. In 
vitro measurements have indicated that α-tocopherol scavenges the peroxyl radicals 
considerably faster than the peroxyl radical reacts with lipid substrate (Wang & Quinn, 
2000). α-tocopherol is able to reduce the free radical making it insufficiently reactive to 
participate in further hydrogen atom abstraction reactions (Bowry & Stocker, 1993; 
Josephy & Mannervik, 2006; Sachdeva et al., 2014).  
A prolonged oxidation of fatty acid side-chains and generation of aldehydes eventually 
disrupts the membrane integrity by altering its fluidity, inactivating membrane-bound 
proteins (e.g., sodium pump) and impairing membrane receptors (Ayala et al., 2014; 
Borja-Cacho & Matthews, 2008). Interestingly, there is important data linking lipid 
peroxidation with mitochondrial dysfunction. The mitochondrial subunits of complexes I 
and IV become covalently crosslinked after reaction with the lipid hydroperoxyl radicals 
(LOO•) and the aldehydes produced during lipid peroxidation, consequently causing 
protein damage. Indeed, upon aging, frontal cortex and hippocampal mitochondria show 
a decreased rate of respiration, with decreased enzymatic activities of complexes I and IV 
and increased content of oxidation products (Repetto et al., 2012). 
3.2 Nucleic Acid Oxidation  
ROS also affect nucleic acids causing several types of damage: bases and sugar 
modification, single and double strand breaks and DNA–DNA or DNA–protein cross-
links (Bartesaghi & Radi, 2018; Coppedè & Migliore, 2014; Dizdaroglu, 1991; 
Mangialasche et al., 2009). In addition, nucleic acids can undergo nitrosative damage by 
RNS, which may promote nitration and deamination of purines. Therefore, 
oxidative/nitrosative injury to DNA and RNA can interfere with correct base pairing, 
impair transcriptional and post-transcriptional pathways, thus compromising protein 
synthesis (Mangialasche et al., 2009). Interestingly, a study has revealed a remarkable 15 
• LOO• + L• →  LOOL  
• LOO• + LOO• →  LOOL + O2 
• L• + L•→  LL 
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fold increase in oxidized nucleotides in brain mtDNA with age. Mitochondrial respiratory 
chain genes are located not only on nuclear (Nu)DNA but also on mtDNA, and with a 
mutation rate 10 times greater than that of NuDNA and less effective repair mechanisms, 
the proximity of mtDNA to oxygen makes it a susceptible target for mutations. This can 
explain the efficiency disruption of the electron transport chain and the further oxidative 
stress increase with aging. Moreover, the ability of cells to respond to oxidative damage 
also seems to decline with age, leading to genome instability and accumulation of 
damaged proteins, which consequently results in altered cellular behaviour and cell death 
(Bartesaghi & Radi, 2018; Coyle & Puttfarcken, 2016; Mecocci, MacGarvey, & Beal, 
1994). Therefore, damage to nuDNA and mtDNA may promote neuronal death through 
defects in oxidative phosphorylation and cell metabolism (Moreira et al., 2008) 
3.3 Protein Oxidation 
Protein oxidation is central in the pathogenesis and development of various 
neurodegenerative diseases, including Alzheimer’s, Parkinson’s, Huntington’s or ALS, 
and can occur directly via ROS/RNS or by secondary attack via lipid peroxidation end-
products (Costa, Quintanilha, & Moradas-Ferreira, 2007). Oxidative and nitrosative stress 
may induce reversible or irreversible changes in proteins. Reversible changes, involved 
in the mechanism of redox regulation, take place mainly on the cysteine aminoacids and 
can be reversed by thioredoxin or glutaredoxin enzymes. Methionine is also liable to 
oxidation, leading to the formation of the methionine sulfoxide, repairable by the action 
of the methionine sulfoxide reductase (Costa et al., 2007; Pastore, Petrillo, Piermarini, & 
Piemonte, 2015). However, the vast majority of oxidative protein modifications are 
irreversible: protein fragmentation due to oxidation of the protein backbone, aggregation 
via covalent cross-linkages, protein carbonylation (introduction of carbonyl groups, 
principally ketones and aldehydes) and protein nitration (Barelli et al., 2008; Berlett & 
Stadtman, 1997; Mangialasche et al., 2009). Overall, these events result in intra and inter-
cellular disrupted communications, which compromise cellular processes (Berlett & 
Stadtman, 1997; Davies, 2016). If the molecular chaperones cannot reconstitute the native 
structure of oxidized proteins and prevent their aggregation, the modified proteins 
become a target for proteolysis and degradation (Bader & Grune, 2006). However, severe 
oxidation causes a decrease in proteolytic susceptibility due to protein aggregation and 
cross-linking, also being able to inhibit proteasome activity. Therefore, failure to remove 
early oxidized proteins may allow for more severe modifications, generating 
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‘indigestible’ protein aggregates (Sweeney et al., 2017). These aggregates reportedly 
exert toxic effects and have been linked to the initiation and progression of numerous 
diseases (Bader & Grune, 2006; Goto & Radak, 2013). Therefore, in order to maintain 
cellular homeostasis and prevent the accumulation of highly oxidized and crosslinked 
proteins, degradation of mildly oxidized proteins is an essential function. 
One hallmark of nitrosative stress is the nitration of protein tyrosine, in which the 
substitution of a hydrogen by a nitro group (-NO2) in the position 3 of the phenolic ring, 
generates 3-nitrotyrosine (3-NT). The nitration mechanism comprises the reaction of 
nitrating species (mainly peroxynitrite) with tyrosine to form tyrosyl radicals (Tyr•), 
which, in turn, recombine with nitrogen dioxide (NO2) to produce 3-nitrotyrosine (Barelli 
et al., 2008). Moreover, lipid radicals can also oxidize tyrosine to Tyr• in membranes, 
promoting nitration reactions. Therefore, and considering that protein tyrosine nitration 
is consistently observed in several pathologies including neurodegenerative diseases, 3-
NT has been established as a biomarker of oxidative stress in vivo, being revealed as a 
strong predictor of disease onset and progression (Ahsan, 2013; Bartesaghi & Radi, 2018) 
4 | Impaired protein homeostasis and Neurodegeneration 
Protein folding is the physical process by which a protein folds into its functional three-
dimensional structure, known as the native state. This self-assembly process results from 
the interactions between the side chains of their constituent amino acids and is stabilized 
and catalysed by chaperones. However, inherited DNA mutations, random mutations, as 
well as oxidative damage can result in modified protein sequence, conformation and 
activity. If under normal physiological conditions the misfolded protein cannot be 
properly refolded by chaperones, systems such as the proteasome, autophagy and ER- 
associated degradation (ERAD) are deployed to degrade these misfolded proteins 
(Valastyan & Lindquist, 2014). Still, some abnormal aggregation-prone proteins are not 
easily recognized and degraded by the defensive proteostasis mechanisms, which can also 
become overloaded and unable to keep up with the misfolded proteins and aggregates 
(Sweeney et al., 2017; Valastyan & Lindquist, 2014). Evidently, the accumulation of 
misfolded proteins into aggregates is harmful to the cell, not only due to the loss of the 
normal protein function, but also due to the aggregates’ ability to sequester other proteins 
or inappropriately interact with other cellular components, causing cellular stress (Stefani 
& Dobson, 2003). Moreover, the accumulation of one species of misfolded proteins 
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seems to contribute to the progressive disruption of the entire proteostatic network, which 
ends up affecting the folding of unrelated proteins (Gidalevitz, Ben-Zvi, Ho, Brignull, & 
Morimoto, 2006; Sweeney et al., 2017). Interestingly, different forms of a given disease 
protein have been observed during aggregation (monomers, oligomers, fibrils, mature 
fibrils) and evidence has emerged showing that, whereas soluble monomers or oligomers 
of misfolded proteins are toxic species, the insoluble, mature fibril aggregates (amyloid-
like) might be cytoprotective (Swart et al., 2014; Tutar, zgur, & Tutar, 2013).  
In the long term, the neurotoxic misfolded protein aggregates deposited in the central 
nervous system, intra and/or extracellularly, cause stress, synaptic dysfunction and 
ultimately neuronal loss (Sweeney et al., 2017; Tutar et al., 2013). To give just a few 
examples, the aggregations include intranuclear neuronal inclusions formed by various 
proteins with abnormally expanded polyglutamine (polyQ) tracts, such as the Htt protein 
in Huntington's disease (HD); intracellular inclusion bodies such as Lewy bodies (LBs) 
in Parkinson's disease (PD); and intracytoplasmic neurofibrillary tangles as well as 
extracellular amyloid deposits in Alzheimer's disease (AD) (Swart et al., 2014). The 
excess amounts of the pathogenic species, which accumulate with age, evoke cytotoxic 
mechanisms that include calcium signaling abnormalities, inhibition of proteasomal 
machinery, mitochondrial dysfunction leading to increased oxidative stress, ER stress 
and, ultimately, activation of cell death cascades (Swart et al., 2014).  
Oxidative stress has been consistently pointed out as a common pathophysiological 
mechanism underlying various neurodegenerative disorders (Kim, Kim, Rhie, & Yoon, 
2015), with various indices of ROS damage reported within the specific brain region that 
undergoes selective neurodegeneration, in cases of PD, AD and Amyotrophic lateral 
sclerosis (ALS) (Andersen, 2015). The relationship between the accumulation of 
misfolded disease proteins and the signs of oxidative stress is mutually exacerbating, 
placing oxidative stress as a cause as well as a consequence of neurodegeneration. Indeed, 
increased oxidative stress can not only cause proteins to misfold, it also contributes to 
impaired proteostasis, especially with aging. On the other hand, inherited or acquired 
mutations affecting certain proteins also cause oxidative stress and neurodegeneration 
(Andersen, 2015; Swart et al., 2014). The brain is actually particularly vulnerable to 
damage caused by ROS/ RNS, not only because of its high oxygen consumption and high 
lipid content (Floyd & Carney, 1992), but also because it is lower in antioxidant activity 
in comparison with other tissues, such as the liver (Uttara, Singh, Zamboni, & Mahajan, 
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2009). Moreover, the human brain has higher levels of iron in certain regions, which 
potentiates radical formation. In addition, protein quality control is also particularly 
challenging in neurons, not only because they have a unique cellular structure with long 
extensions, but most importantly, because neurons cannot dilute toxic substances by 
division. Therefore, neurons are highly sensitive to misfolded proteins, especially as they 
age (Ciechanover & Kwon, 2017), which associates well with the late onset and 
progression of neurodegenerative diseases (Coyle & Puttfarcken, 2016).  
5 | Redox Biomarkers  
Since several studies have demonstrated an increase in oxidative/nitrosative stress in 
patients suffering from central nervous system diseases, like AD, PD, ALS, HD and 
cerebro-vascular diseases (Mangialasche et al., 2009), many efforts have been made in 
order to identify and determine stable redox biomarkers that could reflect the biological 
redox status (Marrocco et al., 2017; Shi, Caudle, & Zhang, 2008). Testing for redox 
biomarkers in neurodegenerative disorders could offer a better insight into the 
development and staging of the diseases and also offer the possibility of monitoring the 
modulation of oxidative stress levels with antioxidant therapies (Brewer, 2011; Lloret et 
al., 2009; Marrocco et al., 2017) The search for biomarkers uses biochemical indices of 
brain dysfunction, measured in body fluids (Cerebrospinal fluid, plasma and urine) or 
neuroimaging techniques to monitor brain changes (Shi et al., 2008). 
5.1 3-Nitrotyrosine  
3-Nitrotyrosine (3-NT) is the main product of  tyrosine (Tyr) oxidation and nitration, 
which is promoted by the peroxynitrite (ONOO−) reaction with CO2. This reaction yields 
secondary radicals (CO3
•–, •NO2 and oxo-metal complexes) that will, in a two-step 
process, i) generate a tyrosine radical by oxidation and ii) nitrate the tyrosine radical, 
generating 3-NT (Fig. I). Nonetheless, 3-NT may also be generated through the catalysis 
of heme-containing proteins. Since most proteins contain Tyr residues and because Tyr 
residues are often surface-exposed (due to mildly hydrophilic character), they are also 
more prone to nitrosative damage. The nitration of protein Tyr residues can dramatically 
change protein structure, conformation and function, leading to pathological protein 
accumulation (Yamakura, Taka, Fujimura, & Murayama, 1998). For example, the 
inactivation of human MnSOD by ONOO− is caused by exclusive nitration of tyrosine 34 
(Tyr34) to 3-nitrotyrosine (Yamakura et al., 1998). Indeed, ONOO− is a destructive free 
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radical oxidant, capable of promoting the oxidation of several lipoproteins and of nitrating 
Tyr residues in many proteins. However, its production is difficult to detect so usually 3-
NT is used as the detectable marker for indirectly detecting ONOO− levels (Ahsan, 2013; 
Bartesaghi & Radi, 2018; Teixeira, Fernandes, Prudêncio, & Vieira, 2016). Increased 
levels of 3-NT are detected in many different diseases, including several 
neurodegenerative diseases (AD, PD, ALS) (Mangialasche et al., 2009; Pastore et al., 
2015). Nitrotyrosine has also been linked to the degeneration of dopamine neurons, since 
tyrosine is the precursor of the neurotransmitter  dopamine (Pastore et al., 2015).  
 
Figure I | Nitration of tyrosine to 3-nitrotyrosine. Adaptad from (Ahsan, 2013) 
5.2 GSH and GSSG 
Glutathione (GSH) is a tripeptide (Glu-Cys-Gly) and is the most important low molecular 
weight antioxidant synthesized in cells. Physiologically, GSH occurs mostly in its 
reduced form, which can be oxidized to GSSG under oxidative stress and is found in 
nearly every compartment of the cell (including the nucleus), even though 90% is stored 
in the cytosol, 10% in the mitochondria and a small fraction in the endoplasmic reticulum. 
GSH is used by the glutathione peroxidases (GPx) as an electron donor to catalyze the 
reduction of H2O2 and organic hydroperoxides to water/alcohols, thus counterbalancing 
the production of ROS. An impaired GPx activity has been reported in several 
neurodegenerative diseases. The GSH is also used by the glutathione S-transferase (GST) 
for the purpose of detoxification; GST catalyses the conjugation of GSH, via a sulfhydryl 
group, to electrophilic centers on a wide variety of substrates, increasing their water-
solubility. Endogenous compounds, such as  peroxidised lipids,  and xenobiotics are then 
easier to detoxify and break down. Impaired expression of GST as well as impaired 
activity have also been reported in neurodegenerative diseases. The enzyme glutathione 
reductase (GR) is responsible for catalyzing the conversion of GSSG back to its reduced 
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form, GSH, using NADPH as an electron donor (Fig. II) (Forman, Zhang, & Rinna, 2010; 
Franco, Schoneveld, Pappa, & Panayiotidis, 2007; Pastore et al., 2015). This Gluthathione 
antioxidant system is the first line of antioxidant defense against ROS. Therefore, the 
GSH:GSSG ratio is critical and must be balanced, with GSH exceeding 100/1 the GSSG. 
However, under oxidative stress the ratio drops to 10/1 (Pallardó, Markovic, & Viña, 
2008). A protective effect against diseases or toxic insults, in vivo or in vitro, with the 
administration of GSH has been reported in several studies, whereas GSH depletion 
showed worsening effects. In fact, the depletion of GSH is associated with oxidative stress 
in a variety of pathological conditions (Chi, Ke, Luo, Gozal, & Liu, 2007; Ghezzi & 
Simplicio, 2008; Mandal, Saharan, Tripathi, & Murari, 2015; Mischley et al., 2016) 
 
Figure II | Glutathione cycle. GSH is converted to its oxidized form, glutathione disulfide (GSSG), by the glutathione 
peroxidase, serving as an electron donor to catalyse the reduction of H2O2. Once oxidized, GSSG can be reduced back 
to GSH by glutathione reductase, using NADPH as an electron donor. Adapted from (Anjaneyulu, Berent-spillson, & 
Russell, 2008). 
6 | Vitamin E 
6.1 The nature of α-tocopherol (Vitamin E)  
The term “vitamin E” is used to describe a group of lipophilic molecules, very similar 
structurally, which is composed by four tocopherols and four tocotrienols, all occurring 
in α, β, ϒ and δ forms. One of the most important roles of Vitamin E, an ubiquitous 
component of cell membranes, is its antioxidant activity. Naturally, Vitamin E can be 
found in fats, vegetable oils, legumes, egg yolks, nuts and seeds (Berman & Brodaty, 
2004; Rizvi et al., 2014). α-tocopherol is the form of Vitamin E most abundant in nature 
and comprises about 90% of all tocopherols found in the tissues of animals, including 
humans. This is probably due to the hepatic α-tocopherol transfer protein (α-TTP), which 
preferentially secretes a‐tocopherol, over other forms, into the plasma (Mustacich, Bruno, 
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& Traber, 2007). The antioxidant properties of vitamin E have been studied in the context 
of preventing or ameliorating the symptoms of diseases highly associated with oxidative 
stress, such as cardiovascular diseases, cancer and neurodegenerative disorders (Wang & 
Quinn, 2000). In fact, deficiency of vitamin E in humans, usually for reasons ranging 
from impaired absorption to genetic abnormalities in the α-TTP, may cause neurological 
problems, such as “cerebellar ataxia, dysarthria, absence of deep tendon reflexes, 
vibratory and proprioceptive sensory loss, and positive Babinski sign” as well as immune 
response problems. However, administration of tocopherol can stabilize or completely 
reverse most of the symptoms (Brigelius-Flohé & Traber, 1999). 
The molecular structure of α-tocopherol (Fig. III) consists of a chromanol ring that is 
methylated at all three available positions on a benzene ring, which is attached to a 16-
carbon saturated phytyl chain. The hydroxyl group (HO) on the benzene ring is 
responsible for the antioxidant activity. This hydrophilic group is usually near the 
aqueous interface, anchored to the membrane by the phytyl chain that extends towards 
the hydrophobic core of the membrane (Leng et al., 2015). It is known that the phytyl side 
chain of α-tocopherol is required for its incorporation and retention in the membranes and 
lipoproteins (Howard, McNeil, & McNeil, 2011; Nikis, Kawakami, Yamamoto, 
Tsuchiya, & Kamiya, 1985; Ulatowski & Manor, 2013). 
6.2 Absorption and distribution 
In humans, after solubilization by pancreatic esterases and bile acids, Vitamin E is 
absorbed by intestinal cells, incorporated into chylomicrons and secreted into the lymph. 
Once it reaches the liver, α-TTP selectively incorporates α-tocopherol into very-low-
density lipoproteins (VLDLs), which are then secreted into the plasma. In the 
bloodstream, the VLDLs are catabolized to low-density lipoproteins (LDLs) and, in this 
Figure III| Molecular structure of α-tocopherol (Vitamin E). Image obtained with ChemDraw JS. 
Phytyl Chain  
Chromanol Ring  
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process, all of the circulating lipoproteins become enriched with α-tocopherol   
(Mustacich et al., 2007; Schmölz, Birringer, Lorkowski, & Wallert, 2016). α-tocopherol   
has been shown to move actively between lipoproteins of different density classes 
(VLDL, LDL and HDL) (Kostner et al., 1995).  
The distribution of α-tocopherol, being a lipophilic molecule, tends to be associated with 
other lipids; allocating within lipid storage organelles and the hydrophobic domains of 
cell membranes. In fact, of all the subcellular membrane fractions, the greatest 
concentrations of α-tocopherol are found in the Golgi membranes, lysosomes and 
mitochondria (Wang & Quinn, 1999; Wang & Quinn, 2000) which seems to correlate 
well with the higher content of these membranes in PUFAs (Buttriss & Diplock, 1988).  
In the CNS, the provisioning of α-tocopherol   to neurons is primarily done by astrocytes. 
These supporting cells regulate lipid transport to neurons by synthesizing and secreting 
apoE-containing lipoproteins, which are critical for the redistribution of cholesterol and 
phospholipids in the brain (Borja-Cacho & Matthews, 2010; Huang & Mahley, 2015); 
indeed, apoE-/- mice have lower brain vitamin E levels (Shimmyo, Kihara, Akaike, 
Niidome, & Sugimoto, 2008). Also, α-TTP regulates apoE-mediated egress of α-
tocopherol   from the astrocytes to the neighbouring neurons. The expression of α-TTP is 
increased under oxidative stress conditions, suggesting an increase in vitamin delivery in 
order to protect neurons from oxidative stress (Ulatowski & Manor, 2013) 
6.3 α-tocopherol   mechanisms of action 
i. Antioxidant activity 
Reactive intermediates produced under conditions of oxidative stress cause the oxidation 
of lipids, especially of polyunsaturated fatty acids (PUFAs). α-tocopherol is the most 
effective lipid-soluble chain-breaking antioxidant present in biological membranes, 
seemingly accumulating where it is most required. Vitamin E’s chromanol-head group, 
located within the hydrophilic portion of the bilayer, scavenges lipid peroxyl radicals by 
donating a hydrogen atom from an intact hydroxide group to the free radical, stabilizing 
it. This way, the propagation chain of free radicals is stopped and the formation of more 
radical species prevented (Berman & Brodaty, 2004; Howard et al., 2011; Niki, 2014; 
Niki & Noguchi, 2004; Phaniendra, Jestadi, & Periyasamy, 2015).  
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The antioxidant reaction is shown below, where LOO• represents a lipid peroxyl radical 
and α-TOH represents α-tocopherol. α-TOH is oxidized in the process of donating an 
electron to LOO•, thus becoming a α-tocopheroxyloxyl radical (α-TOH•). The lipid 
peroxyl radical becomes a relatively stable hidroperoxide, LOOH: 
The α-tocopheroxyloxyl radical formed, highly unstable, reacts either with a second lipid 
peroxyl radical or with a water-soluble antioxidant. The latter allows for the recycling of 
α-tocopherol. Each α-tocopherol molecule can donate two electrons before being 
consumed. The original state of α-tocopherol can be regenerated by a reduction reaction 
with hydroxyl groups from other antioxidants such as vitamin C (ascorbic acid) or 
ubiquinol (Niki & Traber, 2012; Tucker & Townsend, 2005). Interestingly, some studies 
found that a water-soluble vitamin E homologue, Trolox, which has the same chemical 
reactivity towards ROS, but limited access to the radicals within the membrane, was much 
less effective at inhibiting erythrocyte hemolysis induced by ROS than α-tocopherol. This 
highlights the importance of α-tocopherol location within the cell membranes in order to 
effectively break the propagation chain (Niki, 2014). Actually, studies have demonstrated 
that although the concentration of α-tocopherol is comparatively very low in relation to 
phospholipids (approximately one mole of α-tocopherol to 1,000 moles of phospholipid) 
(Atkinson, Epand, & Epand, 2008; Burton, Cheeseman, Doba, Ingold, & Slater, 1983), 
α-tocopherol clusters with microdomains enriched with PUFAs, which favours the 
encounter with lipid peroxyl radicals. These microdomains tend to be more curved and 
more fluid than other membrane regions (Ulatowski & Manor, 2013). Also, it is 
postulated that the chromanol group of α-tocopherol lies near the membrane surface the 
majority of the time, where it can easily reach water-soluble reducing agents necessary 
for the restoration of α-tocopherol antioxidant activity; however, the loosely packed 
PUFAs allows for an easy flip-flop movement of α-tocopherol within the bilayer. By 
bringing the chromanol group from the surface to the hydrophobic interior of the 
membrane, and vice versa, α-tocopherol is able to “patrol” both sides of the membrane 
and exert its radical scavenger activity efficiently (Leng et al., 2015).  
ii. Membrane stabilizer 
Vitamin E is also associated with the function of being a membrane stabilizer. The 
presence of vitamin E at the hydrophobic core of the plasma membrane, changes the 
• LOO• + α-TOH  →  LOOH + α-TOH• 
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bilayer physical properties, such as fluidity. α-tocopherol is believed to form complexes 
with free fatty acids and lysophospholipids (products of membrane lipid hydrolysis), 
which have a tendency to destabilize the bilayer structure. The formation of these 
complexes result in a tighter packaging of the membrane lipids, which increases the 
stability of the membrane. Thereby, α-tocopherol contributes to the maintenance of 
membrane integrity (Rizvi et al., 2014; Wang & Quinn, 2000).   
6.4 Vitamin E Depletion 
Low levels of Vitamin-E in patients might be caused by low vitamin E dietary intake, 
genetic or absorption related problems or even as a consequence of high levels of 
oxidative stress. Remarkably, Vitamin E is preferentially conserved in neural tissues than 
in non-neural tissues; after 52 weeks of vitamin E depletion, the nervous tissues of mice 
still retained 5% of the normal α-tocopherol levels (Goss-Sampson, MacEvilly, & Muller, 
1988), whereas other tissues were depleted of α-tocopherol    after just a few weeks (Bieri, 
1972). A biphasic α-tocopherol depletion is suggested for most tissues: an initial phase of 
rapid loss (4-8 weeks), followed by a second phase of slow depletion (Bourre & Clement, 
1991). It seems plausible that the α-tocopherol mobilized in the first phase comes from 
the labile pool while the retained α-tocopherol should come from sub-cellular structures, 
where it is critical (Machlin & Gabriel, 1982). A redistribution of α-tocopherol from non-
neural tissues to neural tissues during vitamin E deficiency was also observed (Muller, 
Lloyd, & Wolff, 1983). Interestingly, certain regions of the brain, including the forebrain 
and cerebellum, do not follow the biphasic pattern (Bourre & Clement, 1991); the 
biological half-life of vitamin E in the brain is uniquely slow, indicating tissue-specific 
mechanisms that regulate a CNS-specific Vitamin E pool (Muller et al., 1983).  
6.5 Vitamin E in the treatment of neurological disorders  
Studies on Vitamin E deficiency and supplementation have been made in order to evaluate 
possible beneficial effects on neurological disorders.   
i. Alzheimer’s disease 
Studies on Alzheimer’s disease have reported lower concentrations of Vitamin E in the 
CSF of Alzheimer’s patients. In parallel with this result, an increased susceptibility of 
CSF to in vitro oxidation and elevated CSF markers of in vivo lipid peroxidation were 
also found in AD patients, indicating that oxidative stress probably has a role in the 
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vitamin E depletion (Kontush & Schekatolina, 2004). In a different study, 
supplementation with Vitamin E alone or in combination with vitamin C, significantly 
increased the CSF and plasma levels of vitamin E in AD patients. Also, the combined 
supplementation significantly decreased the susceptibility of CSF lipoproteins to in vitro 
oxidation in the presence of low amounts, but “physiologically relevant”, oxidants 
(Kontush et al., 2001). Natural high plasma levels of vitamin E among old individuals 
were also found to be associated with lower risk of AD development (Mangialasche, 
Kivipelto, Mecocci, Rizzuto, & Palmer, 2010). Moreover, in a transgenic mice model of 
AD, dietary supplementation with vitamin E seemed to have beneficial effects regarding 
disease progression; both lipid peroxidation and amyloid-β deposition in the brain of 
young mice (5 months) were reduced. Supplementation at a later age (14 months), 
however, did not show any beneficial effects. These results put in evidence a pathological 
role of oxidative stress on AD early on, before amyloid deposition (Sung et al., 2004). 
Amyloid-β is a potent meta-chelating antioxidant (in its monomeric form) carried by 
lipoproteins. Therefore, the accumulation of amyloid-β peptide in the brains of AD 
patients can be regarded as a protective response to elevated oxidative stress. However, 
the increase in the amyloid-β production also increases the likelihood of aggregation and 
fibrillation, induced by the chelation of transition metal ions present (particularly copper). 
Fibrillated amyloid-β is able to produce reactive oxygen species, further aggravating 
oxidative stress in AD brain (Kontush, 2001; Kontush & Schekatolina, 2004). Therefore, 
the results suggest that treatment with antioxidants, such as vitamin E, should be helpful 
at an early stage of the disease or preferably, as a form of prevention (Sung et al., 2004) 
However, trials with AD patients or patients suffering from mild cognitive impairment 
and supplementation with Vitamin E have presented controversial results. Some suggest 
a beneficial role for vitamin E: slower rate of progression to AD or smaller risk of 
developing it (Dysken et al., 2014; Kontush et al., 2001; McIntosh, Trush, & Troncoso, 
1997; Morris et al., 1998, 2002; Zandi et al., 2004); interestingly, one study reported 
improvement on cognitive performance of subjects free of dementia that were taking 
vitamin E supplements (Berg et al., 2000). Some studies, however, do not find significant 
differences with or without vitamin E supplementation (Berg et al., 2000; Kontush & 
Schekatolina, 2004; Luchsinger, Tang, Shea, & Mayeux, 2003). One study even found 
that vitamin E supplementation can be detrimental to some AD patients (Lloret et al., 
2009). Remarkably, however, most studies report beneficial results with a combined 
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supplementation of Vitamin E and C, on oxidative stress, AD progression or AD risk 
(Foley & White, 2002; Kontush et al., 2001; Morris et al., 1998; Zandi et al., 2004), which 
is probably due to the vitamin C capacity to regenerate α-tocopherol. Recently though, a 
study on the effect of one year vitamin E and C supplementation in patients with AD, 
revealed no beneficial effects on cognitive decline, despite the increase in vitamin 
concentrations in CSF and reduced in vitro oxidation of CSF lipoproteins after just one 
month of supplementation (Arlt, Muller-Thomsen, Beisiegel, & Kontush, 2012). 
ii. Parkinson’s Disease 
Regarding Parkinson’s Disease, decreased α-tocopherol and α-tocopherol   quinone CSF 
levels were reported in 15 untreated PD patients compared with 14 controls (Tohgi et al., 
1995). The risk of PD was shown to be significantly reduced among subjects with high 
intake of dietary vitamin E; however, supplementation with synthesized Vitamin E did 
not show beneficial results. This difference might be explained by the presence of other 
antioxidants in foods (Zhang, Hern, Chen, & Spiegelman, 2002). Moreover, since 
mitochondria oxidative stress is highly correlated with PD, one study tested the 
enrichment of α-tocopherol in mitochondria of mice subjected to increased concentrations 
of dietary α-tocopherol. The results showed a significant increase of α-tocopherol in 
mitochondria from liver and brain tissues of mice fed diets high in α-tocopherol. Hence, 
the use of chronic dietary α-tocopherol supplementation was proposed as a therapeutic 
strategy for the prevention or treatment of PD (Fariss & Zhang, 2003). 
iii. Amyotrophic Lateral Sclerosis 
Studies have demonstrated an association between long-term vitamin E supplement use 
and lower ALS risk (H. Wang et al., 2011; Wunderink, Koster, Vries, Luyt, & Wokke, 
2007) as well as slower progression (Ascherio et al., 2005; Desnuelle, Dib, Garrel, & 
Favier, 2001; Mustacich, Bruno, & Traber, 2007) 
iv. Huntington Disease 
α-tocopherol protected neuronal cells against glutamate induced cytotoxicity and 
attenuated cell death in a dose dependent manner (Miyamoto, Murphy, Schnaar, & Coyle, 
1989). Another study revealed α-tocopherol to have beneficial effects on Huntington 
disease patients only when taken at an early stage of the disease. Late stage 
supplementation seemed to worsen the patients neurological conditions when compared 
to controls (Johri & Beal, 2012; Peyser et al., 1995). 
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6.6 The Dual Nature of Vitamin E and The Clinical Trial Controversial 
Results 
Behind the controversial results on vitamin E supplementation, seems to be its dual 
nature. Vitamin E has been showed to consistently exert its antioxidant activity in strong 
oxidative conditions (high ROS content) (Lam, Stocker, & Dawes, 2010). But it has also 
been documented that on plasma lipoproteins, which are associated with only mild 
oxidative conditions, α-tocopherol actually acts as a pro-oxidant, by a mechanism of 
tocopherol-mediated peroxidation (Bowry & Stocker, 1993). Paradoxically, a computer 
model of the influence of Vitamin E on lipoprotein oxidation revealed that in CSF 
lipopoliproteins, which are also associated with mild physiological oxidative conditions, 
α-tocopherol acts not as a pro-oxidant, but as an antioxidant. By contrast, when these 
oxidative conditions are virtually increased, α-tocopherol develops antioxidant activity, 
both in plasma and CSF lipoproteins (Kontush & Schekatolina, 2004). Therefore, it is 
hypothesised that in low fluxes of oxygen radicals, the α-tocopheroxyl radicals (highly 
unstable) have lower probabilities of reacting with peroxyl radicals, which makes them 
more available to react and oxidize other PUFAs. Hence, the antioxidant activity of α-
tocopherol observed in CSF lipoproteins, but not in plasma, should relate to differences 
in the ratios of vitamin E and oxidizable lipids, between CSF and plasma. In other words, 
there is different oxidative conditions per unit of vitamin E, in the presence of similar 
amounts of oxidants. Moreover, the presence of other water soluble electron acceptors, 
such as vitamin C, ubiquinol-10, GSH, NADH, cysteine or pyruvate, capable of 
regenerating α-tocopheroxyl radicals back to α-tocopherol, seems to be of the utmost 
importance for the maintenance of the antioxidant nature of Vitamin E (Bowry & Stocker, 
1993; Brewer, 2011; Kontush, Finckh, Karten, Kohlschutter, & Beisiegel, 1996; Kontush 
et al., 2001; Kontush & Schekatolina, 2004).  
Therefore, one of the reasons appointed for the controversial results on vitamin E 
supplementation is the toxicity associated with high doses intake, which may not be 
efficient in preventing chronic degenerative diseases, and may, in fact, increase mortality 
(Lloret et al., 2009). Notwithstanding, vitamin E does seem to have a beneficial effect on 
diminishing the prevalence or progression of neurodegenerative diseases when taken at 
an early stage, which implies a timing importance. Furthermore, the best results are 
obtained when vitamin E supplements are consumed along with vitamin C supplements 
or when associated with diets enriched with other antioxidants. This is in line with the 
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dual nature of vitamin E, which is dependent on the redox potential in the local cellular 
environment (Bowry & Stocker, 1993; Jones, 2002), Loret et al. (Lloret et al., 2009) 
hypothesizes that having an oxidized plasma redox potential (lower plasma GSH:GSSG 
ratio) can energetically block the removal of reactive species. Therefore, age, genetics, 
environmental and behavioural individual differences may all play a critical role on the 
outcome of vitamin E supplementation (Azzi, Gysin, & Kempn, 2003). In this context, 
Brewer, Gregory J. proposes that vitamin E supplementation therapies [for AD] should 
aim for a reductive shift in the metabolically oxidized redox potential (Brewer, 2011). 
7 | Saccharomyces cerevisiae as model of study for Neurodegenerative Disorders   
S. cerevisiae was the first eukaryotic organism to have its genome fully sequenced, in 
1996 (Tenreiro & Outeiro, 2010). Since then, the yeast has become a biological resource 
widely used in the research field (Menezes, Tenreiro, Macedo, Santos, & Outeiro, 2015). 
A fundamental aspect for using yeast as a model of study is the conserved cellular 
pathways between yeast and humans, such as cell division, DNA replication, metabolism, 
protein folding and intracellular transport, which were first identified in yeast and then 
shown to be conserved in higher eukaryotes (Franssens et al., 2013; Menezes et al., 2015; 
Miller-fleming, Giorgini, & Outeiro, 2008; Pereira, Bessa, Soares, Leo, & Saraiva, 2012). 
Actually, about 30% of the genes associated with human diseases seem to have yeast 
orthologues. Therefore, two types of studies can be performed. If the yeast possesses an 
orthologue gene of a hypothetically disease-causing human gene, then studies of loss or 
gain of function can be made, either by deleting it or by overexpressing it. On the other 
hand, if the desired gene is not conserved, the human protein may be heterologously 
expressed in yeast cells (Oliveira, Vilaça, Santos, Costa, & Menezes, 2017). Yeast models 
engineered to express exogenous human risk genes for synucleinopathies (such as PD), 
HD and other polyglutamine (poly(Q)) diseases, AD, ALS, prion diseases and tauopathies 
are able to recapitulate some key cellular phenotypes (Archiv, 2010; Bharadwaj, Martins, 
& Macreadie, 2010; Kryndushkin & Shewmaker, 2011; Outeiro & Lindquist, 2003; 
Winderickx et al., 2008) and have been used to perform unbiased genetic and chemical 
screens for phenotypic modifiers. The yeast genome is, in fact, very well characterized, 
easy to manipulate genetically, and rather quick and non-expensive when compared to 
other eukaryotes, apart from surviving indefinitely in frozen glycerol stocks. Moreover, 
yeast cells have a high transformation efficiency as well as a very efficient homologous 
recombination pathway, which makes it very easy to insert, delete or mutate genes  
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(Menezes et al., 2015; Tenreiro & Outeiro, 2010). There are already numerous cDNA 
libraries available, as well as collections of yeast strains, and efforts are to generate a 
collection of strains, each harbouring a single mutation. Another advantageous feature of 
this eukaryotic organism is the haploid and diploid forms involved in the cell cycle, which 
simplifies the study of lethal mutations in heterozygous diploids and recessive mutations 
in haploids (Braun, Bu, Ring, Kroemer, & Madeo, 2009; Miller-fleming et al., 2008). 
However, the main advantage of using this simple eukaryotic model might be the 
possibility of largescale genetic screening studies and functional genomics, which allow 
for a rapid and relatively easy way of establishing gene-protein-function associations. 
With the huge amount of genetic and biological data being obtained, a comprehensive 
model of eukaryotic cell functioning is being built (Menezes et al., 2015). The emergence 
of next generation sequencing strategies, together with traditional genetic linkage 
approaches, and genome-wide association studies (GWAS), risk genes associated with 
human diseases are being rapidly discovered (Dhungel et al., 2015). Despite the several 
advantages of yeast models to study human diseases, we should not forget that several 
human mechanisms and biological pathways are absent in the yeast; importantly, yeast 
does not have a nervous system. Also, yeast fails as a model to study the multicellularity 
and cell–cell interactions. Therefore, all findings in yeast related to human disease must 
ultimately be validated in higher eukaryotes, prior to trial in humans (Miller-fleming et 
al., 2008). Nonetheless, yeast models of human diseases are a very useful platform for 
high throughput screens as a first-line of approach in the discovery of new genes that 
might have potential as therapeutic targets, as well as in the identification of new drugs 
with therapeutic value (Tenreiro, Munder, Alberti, & Outeiro, 2013). 
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Objectives 
• Induce oxidative stress in S.cerevisiae cells with H2O2 at different 
concentrations; 
• Explore the antioxidant nature of α-tocopherol (vitamin E) as a modulator of 
oxidative stress induced by H2O2;   
• Understand the association between cell viability rates, after exposure to 
different oxidative conditions, and the levels of the redox biomarkers: 3-
nitrotyrosine and GSH:GSSG ratio. 
 
  
 
 
 
 
 
Chapter II – Materials and Methods 
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1 | Cell Viability Experiments 
1.1 Yeast strain and growth conditions 
i. Samples  
S. cerevisiae samples grown on solid YEPD medium (Sigma-Aldrich®, Portugal) were 
analysed after having been incubated in YEPD broth (Sigma-Aldrich®, Portugal) for 180 
min with: 1) hydrogen peroxide (H2O2) at concentrations of 3 mM and 5 mM; 2) Vitamin 
E (α-tocopherol acid succinate) at concentrations of 5,6 mg/L, 11,3 mg/L and 22,5 mg/L, 
3) H2O2 + Vitamin E (α-tocopherol acid succinate), at all concentrations. 
ii. Strain 
The strain used in the study was S. cerevisiae ATCC® 9763™ available in the laboratory 
of the Department of Chemical Sciences and Biomolecules of School of Health of the 
Polytechnic of Porto. 
iii. Oxidative stress inducing agent 
The agent used to induce oxidative stress was hydrogen peroxide (H2O2) (hydrogen 
peroxide 30%, Merck, New Jersey, USA). 
iv. Antioxidant agent 
α-tocopherol, a type of vitamin E, was used in the form of α-tocopherol acid succinate 
(Sigma-Aldrich®, Portugal) as the antioxidant agent. The compound was solubilized in 
95% ethanol, according to (Sigma-Aldrich®) to a final concentration of 10mg/mL, which 
corresponds to a concentration of approximately 8 mg/mL of α-tocopherol; this solution 
was further filtered at 0,2 μm and stored at 4ºC protected from light.  
v. Culture media and solutions 
Yeast Extract Peptone Dextrose (YEPD) medium (1% yeast extract, 2% bacteriological 
peptone, 2% dextrose, 1,5% agar) (Sigma-Aldrich®, Portugal) was used for solid 
cultures, while YEPD broth (1% yeast extract, 2% peptone, 2% dextrose) was used for 
suspended cultures and pre-cultures. For resuspension and dilution of the cells for sample 
plating, a solution of 0.85% (w/v) NaCl (Carlo Erba Reagents, Val de Reuil, France) was 
employed. The diluted samples were plated on YEPD agar medium (Sigma-Aldrich®, 
Portugal). 
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1.2 Pre-cultures 
Active dry Saccharomyces cerevisiae strains were initially rehydrated in sterile distilled 
water at room temperature for 2h, accordingly with ATCC instructions, and grown at 
30°C on YEPD agar medium for 48h hours. Fresh solid Saccharomyces cerevisiae 
cultures were then established every 48h before the start of an experiment, from a 
previous solid culture. 
After 48h of being plated, S. cerevisiae was inoculated and incubated into 50mL 
Erlenmeyer flasks, containing 10mL of sterile YEPD medium, for approximately 16h, on 
an orbital shaker (130 rpm) at 30ºC. These inoculums were then used to start three 
independent pre-cultures, rapidly achieving an optimal optical density of 0,075-0,100 at 
OD600nm. The pre-cultures were left to grow at 30ºC for 6h, with agitation (130 rpm). It 
was only after this period, during the exponential growth phase of the culture, with an 
OD600nm between 1,500 and 1,880 (0.5 McFarland standard), that the conditions being 
tested were prepared. Absorbance readings were all performed on a UV-Vis 
spectrophotometer (GENESYS™ 20 Visible Spectrophotometer, Thermo Fisher 
Scientific, Wilmington, EUA). 
A S.cerevisiae growth curve of CFU/mL vs incubation time, as well as a growth curve of 
absorbance vs incubation time were previously performed by the group of Chemical 
Sciences and Biomolecules of School of Health of the Polytechnic of Porto. These 
analyses allowed for the experimental design of this work. 
1.4 Testing the effect of H2O2 and vitamin E on viability of yeast cultures 
Each of the three independent pre-cultures, at the exponential growth phase, were equally 
subdivided into four Erlenmeyer flasks of 250mL: one served as the double negative 
control (only YEPD medium), while the others were individually exposed to a 
concentration of H2O2, Vitamin E (α-tocopherol acid succinate), and a combination of 
both. An additional ethanol control was also performed initially, aimed at accessing the 
effects of ethanol on S. cerevisiae viability; the volumes of EtOH tested were the same as 
the respective volumes used for vitamin E experiments. Yeast cultures were then 
incubated at 30ºC for a period of 180 min, with agitation (130rpm). Throughout this 
period, and at 45 min intervals, starting at minute zero (T0), 5mL and 100µL samples 
were taken from each condition and controls. The 5mL samples were stored in falcon 
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flasks at -80ºC for posterior HPLC analysis, while the 100µL samples were resuspended 
and serially diluted 10-fold (10-1-10-5 CFU/mL) in NaCl solution. 
1.5 CFU counting  
10uL of the diluted samples were plated onto YEPD agar, using the drop plate technique 
(Naghili et al., 2013). Culture plates were then incubated at 30ºC for a period of 48h, after 
which the colony-forming units (CFU) were counted and the percentage of cell survival 
determined. All tests were repeated 9 times for each condition. 
1.6 Statistical analysis 
The data obtained from each condition (n=9) was normalized to the value of its respective 
double negative control at T0 time. Statistical analysis was then performed using 
the Two-way Analysis of Variance (ANOVA) test. Data on Table 1 and Graphs is 
presented as the mean of 6 independent measurements ± standard error of the mean 
(SEM). All statistical tests and graphs were performed on GraphPad Prism version 7.04 
(La Jolla, CA, USA). 
2 | Redox biomarkers 3-NT and GSH:GSSG quantification by HPLC 
2.1 3-NT and GSH:GSSG quantification by HPLC 
For 3-NT measurement, HPLC method was performed according to Teixeira et al. 
(Teixeira et al., 2016), while the quantification of GSH and GSSG was performed 
according to a previous work developed by Peixoto, V. at the Department of Chemical 
Sciences and Biomolecules of School of Health of the Polytechnic of Porto. 
2.2 Equipment and software 
All measurements were performed on a Hitachi LaChrom Elite®HPLC system (Hitachi 
High− Technologies Corporation, Tokyo, Japan) composed by HTA L-2130 LaChrom 
Elite quaternary pumps, L-2200 LaChrom Elite autosampler, L-2300 LaChrom Elite 
column heater and L-2455 LaChrom Elite photo DAD. EZChrom Elite Compact Software 
Version 3.3.2. (Agilent Technologies, Inc., Santa Clara, CA, United States) was used for 
data collection and analysis. 
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2.3 Mobile phase 
For the quantification of 3-NT, mobile phase was prepared according to the following 
proportions: 0.5% CH3COOH:MeOH:H2O (15:15:70, v/v) [acetic acid (Merck S.A., 
Algés, Portugal); methanol (Carlo Erba Reagents, Val de Reuil, France); ultrapure water 
obtained from the Water Purification System TKA Barnstead™ GenPure™ capsule 0.2 
µm (Thermo Fisher Scientific, Wilmington, EUA)] and was filtered through a 0.45 µm 
filter membrane. 
For the quantification of GSH and GSSG, mobile phase was prepared according to the 
following proportions: 0,085% H3PO4: H2O (1:99, v/v) [orthophosphoric acid (Merck 
S.A., Algés, Portugal); ultrapure water obtained from the Water Purification System TKA 
Barnstead™ GenPure™ capsule 0.2 µm (Thermo Fisher Scientific, Wilmington, EUA)] 
and was filtered through a 0.45 µm filter membrane. 
2.4 Calibration standards 
Stock solutions of 3-NT (0,5 mg/L) and of GSH and GSSH combined (0,8 mg/L GSH 
and 4,25mg/L GSSG) were prepared using the mobile phases as solvents and filtered 
through a filter membrane device. Standard solutions of 0,2; 0,1; 0,05; 0,02; 0,01 and 
0,005 mg/mL were prepared by diluting the stock solution with the desired mobile phase 
and were used for calibration purposes. 
2.5 HPLC conditions  
Chromatographic conditions used for 3-NT quantification were: flow rate of 1 mL/min; 
detection at 356 nm; volume of injection of 25 µL and oven temperature of 25°C. 
Chromatographic conditions used for both GSH and GSSG quantification were: flow rate 
of 1 mL/min; detection at 225 nm; volume of injection of 25 µL and oven temperature of 
40ºC °C.  
2.6 Sample preparation 
The 5mL samples of S.cerevisiae culture collected during the experiments described 
above, in 45 min intervals, and for all tested conditions, were used to quantify both 3-NT 
and GSH:GSSG ratio.  
The samples for 3-NT quantification were initially submitted twice to a cycle of freezing 
(10 min at -80ºC) and heating (10 min, 100ºC), aiming at the disruption of the cell wall. 
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Subsequently, at room temperature, glass beads (obtained manually by crushing glass to 
powder, in a pestle) were added to 1mL sample on round-bottom 2mL eppendorfs (1:2 
w/w) and vortexed for 5min. The samples were then sonicated (Silent Crusher S at 47–
63 Hz) for 10 min. After sonication, samples were centrifuged for 5 min at 14500 rpm; 
the obtained supernatants were centrifuged again for another 5 min at 14500 rpm and  
stored in a new tube at -80ºC, until appropriate assays for oxidative stress biomarkers 
were performed.  
The samples for GSH and GSSG quantification were not submitted to freezing and 
heating cycles, given the poor temperature stability of these molecules. Therefore, 
immediately after the thawing of the samples, glass beads (obtained manually by crushing 
glass to powder in a pestle) were added, on ice, to 1mL sample on round-bottom 2mL 
eppendorfs (1:2 w/w) and vortexed for 1 min 5 times, each time keeping the cells on ice 
for 1 minute between vortexings. The samples were then sonicated (Silent Crusher S at 
47–63 Hz) for 10 min with cold water and ice. After sonication, samples were centrifuged 
at 14500 rpm for 2 min 5 times, each time keeping the cells on ice for 1 minute between 
centrifugations. The final supernatants obtained were stored at -80ºC, until appropriate 
assays for oxidative stress markers were performed. 
The supernatants stored were then filtered through a filter membrane device of 0.2 µm 
(Whatman™, Maidstone, UK) before HPLC analysis. This process was made on ice for 
GSH:GSSG samples. A control on temperature stability of 3-NT, GSH and GSSG was 
also performed for the disruption methods described. 
2.7 Viability assessment 
After cell wall disruption methods and before the filtering step, 10 µL of yeast cells 
samples were mixed with 10 µL of methylene blue 1% (PanReac AppliChem, Chicago, 
USA) to perform a microscopic analysis (Primo Star, ZEISS, VWR, Primo Star iLED; 
VisiCam 5.0: 630-1032) and assess yeast viability and cell wall integrity. 
2.8 Analysed samples 
One sample of each condition, as well as the respective controls, were analysed by HPLC 
at T0 and T180, only. Statistical analysis was not performed given the sample size.  
Graphs were obtained on GraphPad Prism version 7.04 (La Jolla, CA, USA).  
  
 
  
 
 
 
 
 
Chapter III – Results 
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1 | Cell Viability Experiments 
1.1 Effect of EtOH on S. cerevisiae viability 
The results from ethanol controls did not differ significantly from their own negative 
controls (P>0,05), therefore validating ethanol as safe dissolving agent for acid 
succinate of α-tocopherol to be used in this experiment (Fig.IV). 
 
 
 
 
 
 
 
 
 
 
1.2 Effect of different concentrations of H2O2 and vitamin E on S.cerevisiae 
Viability 
Table III shows the results of the effect of different concentrations of H2O2 and vitamin 
E on S. cerevisiae viability. The experimental groups (G1-G11) exposed to different 
conditions are indicated on the table. All vitamin E-only groups (G1, G2 and G3) showed 
similar results to their own negative controls. Whereas in the groups where cells were 
exposed solely to 3 mM (G4) or 5 mM (G8) of H202, it is evident an accentuated decrease 
in cell viability (𝑃<0.05) of 80,6% and 79,2%, respectively. 
In groups G5, G6, and G7, in which the cultured cells were exposed to H2O2 at 3 mM as 
well as to increasing concentrations of Vitamin E, we reported large differences regarding 
cell viability. Whereas a percentage of cell death of 81,9 and 50,0% was recorded for G5 
and G7, respectively, in G6, the group exposed to an intermediate concentration of 
vitamin E, there was no cell death observed; in fact, a tendency of cell growth is observed. 
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Figure IV | Effect of EtOH on S.cerevisiae viability. Cells were exposed to 112,5 μL of 95% EtOH for 180 min. 
The viability percentage was calculated as the number of c.f.u./mL obtained at each time point divided by the 
number of CFU/mL obtained at time 0 of the respective negative control. Data presented here represents the mean 
± SEM of four independent experiments performed in triplicate (n=12).  
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The results from G5 did not differ significantly from G4 (𝑃>0.05), showing that the lower 
concentration of Vitamin E is insufficient to revert cell death at these oxidative 
conditions. Contrastively, the results from G6 and G7 did differ significantly from G4 
(𝑃<0.05) indicating a protective effect of vitamin E against H2O2; the percentage of cell 
recovery was 30,6% for the higher concentration of Vitamin E and 95,7% for the 
intermediate concentration, which based on these results seems to completely revert the 
oxidant effect of H2O2 on cells (Table III).  
In groups where the cells were exposed to 5 mM of H202 and the same increasing 
concentrations of Vitamin E, the percentages of cell death were inversely related to the 
vitamin concentration, 64,4% for G9, 52,5% for G10 and 38,0% for G11 (see fig.3). 
Moreover, G10 and G11 results significantly differed from G8 at final recovery times 
(T180), but not G9, which seems to indicate once again that the lower concentration of 
vitamin E in unable to revert cell death significantly at these oxidative conditions. G9, 
G10 and G11 did not differed significantly between them. 
Thus, even though the highest value on cell viability was observed for G6, the group were 
cells were exposed both to H2O2 at 3 mM and Vitamin E at 11,3mg/L, a consistent 
tendency on cell recovery improvement was observed for the higher concentration of 
H2O2, 5 mM. Moreover, G11 did not differ from its double negative control at final 
recovery time, indicating a reversal in the oxidative effect of H2O2. 
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Table III | Percentage of viability of S. cerevisiae cells when exposed to different concentrations of H2O2 and 
Vitamin E for 180 min. The viability percentage was calculated as the number of CFU/mL. obtained at each time 
point divided by the number of CFU/mL. obtained at time 0 of the respective double negative control.  Data presented 
here represents the mean ± SEM of six independent experiments (n=6). * = significant difference (Two-way ANOVA 
𝑃 < 0.05) between the condition and its respective double negative control. a, b, c, d, e = significant difference (Two-
way ANOVA 𝑃 < 0.05) between the conditions identified with the same letter, within the same row only.  
 
 
Figure V | Percentage of viability of S. cerevisiae when exposed to different concentrations of H2O2. Cells were 
exposed to H2O2 at 3 mM (G4) and 5 mM (G8), for 180 min. The viability percentage was calculated as the number of 
CFU/mL obtained at each time point divided by the number of CFU/mL obtained at time 0 of the respective double 
negative control. Data presented here represents the mean ± SEM of six independent experiments (n=6). The control 
shown is only indicative, since every condition group has its own double negative control group.  
 
% Cell Viability 
H2O2 
Time 
(min) 
Vitamin E 
 5,6 mg/L 11,3 mg/L 22,5 mg/L 
0 
0 100,0 ± 0,0 100,0 ± 0,0 100,0 ± 0,0 
45 69,6 ± 17,8 79,2 ± 6,3 92,0 ± 5,0 
90 87,7 ± 18,3 108,7 ± 12,6 72,9 ± 11,9 
135 74,6 ± 16,3 95,7 ± 10,1 69,8 ± 12,3 
180 90,5 ± 20,9 118,8 ± 18,4 107,4 ± 11,5 
   
3 
mM 
0 100,0 ± 0,0 100,00 ± 0,0 100,0 ± 0,0 100,0 ± 0,0 
45 41,7 ± 4,2 *  56,2 ± 18,3 62,9 ± 15,3 33,6 ± 4,4  *  
90 14,3 ± 1,6 * b c 44,6 ± 13,8  d 101,0 ± 14,3  b d e 42,1 ± 8,8  c e 
135 9,4 ± 1,5  * a b c 33,0 ± 12,2  * d 124,7± 19,7  b d e 38,4 ± 6,1  * c e 
180 19,4 ± 2,7  * b c 18,1 ± 4,0  * d 115,1 ± 14,6  * b d e 50,0 ± 8,6  * c e 
 
5 
mM 
0 100,0 ± 0,0 100,0 ± 0,0 100,0 ± 0,0 100,0 ± 0,0 
45 34,2 ± 3,5  * a b c  77,0 ± 9,7  a 95,5 ± 9,7  b 72,0 ± 4,9  c 
90 9,0 ± 1,7  * a  52,3 ± 6,1  * a 34,9 ± 8,1  *  37,7 ± 4,2  * 
135 5,7 ± 2,0  * a b c 35,3 ± 5,9  * a d 52,1 ± 9,0  b 71,6 ± 12,9  c d 
180 20,8 ± 2,7  * b c 35,6 ± 7,3 * 47,5 ± 6,2  * b 62,1 ± 18,7  c 
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Figure VI | Percentage of viability of S. cerevisiae when exposed to different concentrations of Vitamin E and to 3 
mM of H2O2. Cells were exposed to 3 mM of H2O2 in combination with 5,6 mg/L vitamin E (G5), 11,3 mg/L vitamin E 
(G6) and 22,5 mg/L vitamin E (G7) for 180 min. The results (CFU/mL) were normalized to their respective control group 
at T0. Data presented here represents the mean ± SEM of six independent experiments (n=6). The control shown is only 
indicative, since every condition group has its own double negative control group. 
 
Figure VII | Percentage of viability of S. cerevisiae when exposed to different concentrations of Vitamin E and to 5 
mM of H2O2. Cells were exposed to 5 mM of H2O2 in combination with 5,6 mg/L vitamin E (G9), 11,3 mg/L vitamin E 
(G10) and 22,5 mg/L vitamin E (G11) for 180 min. The results (CFU/mL) were normalized to their respective control 
group at T0. Data presented here represents the mean ± SEM of six independent experiments (n=6). The control shown is 
only indicative, since every condition group has its own double negative control group. 
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2. HPLC Analysis 
2.1 S. cerevisiae cells viability   
A sample of yeast cells, used as a control, was stained with methylene blue 1% and 
subjected to light microscopy before and after the protocol for yeast cell wall disruption 
with glass beads. S. cerevisiae. In a non-treated condition, yeasts were not stained, 
suggesting an intact cell wall, as expected (image not shown). After treatment, yeast cells 
were indeed stained, indicating non-viability, but continued to present its typical structure 
and a well-defined coloration. 
2.2 3-NT quantification by HPLC 
After treatment for cell wall disruption, samples of each condition, as well as their 
respective double negative controls, at T0 and T180, were subjected to a HPLC analysis.   
Samples were spiked with 3-NT and detection at 356 nm was evaluated. Results are 
shown on Figure IX. 
 
 
 
 
Figure VIII: Light microscopy image of S. cerevisiae after treatment. Methylene blue staining. (Primo 
Star iLED, ZEISS, EUA; 40X magnification) 
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Figure IX | Data represents the percentage of 3-NT levels produced by S. cerevisiae exposed to different 
concentrations of H2O2 and Vitamin E, at T0 and T180. (A) Cells were exposed to 3 mM of H2O2 in 
combination with 5,6 mg/L, 11,3 mg/L and 22,5 mg/L of vitamin E, for 180 min.  (B) Cells were exposed 
to 3 mM of H2O2 in combination with 5,6 mg/L, 11,3 mg/L and 22,5 mg/L of vitamin E, for 180 min. 3-NT 
values of exposure conditions were normalized to their respective control samples. The control shown is 
only indicative, since every condition has its own double negative control. 
 
Although a statistical analysis was not possible, 3-NT levels seem to decrease at the end 
of the experiment (T180) for the combined concentrations of H2O2 at 3 mM and vitamin 
E at 22,5mg/L, comparatively to T0 and to control (A). However, changes on 3-NT levels 
at the conditions of 5 mM of H2O2 are not so clear; all conditions appear to have very 
close values of 3-NT formation (B).  
2.3 GSH and GSSG quantification by HPLC 
After treatment for cell wall disruption, samples of each condition, as well as their 
respective double negative controls, at T0 and T180, were subjected to a HPLC analysis.   
Samples were spiked with GSH and GSSG and detection at 225 nm was evaluated. 
Results are shown on figure X.  
 
A 
B 
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Figure X | Data represents the ratio of GSH:GSSG produced by S.cerevisiae exposed to different 
concentrations of H2O2 and Vitamin E, at T0 and T180. (A) Cells were exposed to 3 mM of H2O2 in 
combination with 5,6 mg/L, 11,3 mg/L and 22,5 mg/L of vitamin E, for 180 min. (B) Cells were exposed 
to 5 mM of H2O2 in combination with 5,6 mg/L, 11,3 mg/L and 22,5 mg/L of vitamin E, for 180 min. GSH 
and GSSG values of exposure conditions were normalized to their respective control samples. The control 
shown is only indicative, since every condition has its own double negative control. 
 
Results from GSH:GSSG quantification were disregarded due to their severe 
inconsistency and poor sample size; values were reported with supposed differences of 
many orders of magnitude, compared to controls.  
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It has been recognized for more than fifty years that adequate levels of vitamin E are 
critical for maintaining neurological health (Ulatowski et al., 2014). Therefore, the use of 
antioxidant supplements as a form of prevention or delaying of symptoms of 
neurodegenerative diseases is not new. However, because their effects are not immediate 
and actually seem to act on a preventive manner, their therapeutic or preventive potential 
has been little explored. The monitoring of antioxidant levels, along with redox 
biomarkers on cerebrospinal fluid, could actually provide an indication of disease onset 
and progress; moreover, it should allow for a modulation of oxidative stress levels 
individually, and, consequently, more efficiently (Hensley et al., 2011). In view of this, a 
preliminary study was designed aimed at understanding the relationship between 
oxidative stress and the role of vitamin E, as an antioxidant, at normal physiological 
concentrations. Future studies on modulation of oxidative stress levels should focus on 
increasing specificity to the area of neurodegenerative diseases. 
Saccharomyces cerevisiae was the eukaryotic model organism chosen for the experiments 
on the present study, given their easy availability and maintenance, high degree of 
conservation of genes and biological processes between yeast to human, short generation 
time and extensive literature (Franssens et al., 2013; Menezes et al., 2015; Miller-fleming 
et al., 2008; Pereira et al., 2012). 
The present investigation studied the effect of H2O2 at the concentrations of 3 mM and 5 
mM, which were based on previous studies using S. cerevisiae and H2O2 as an inductor 
of oxidative stress (Madeo et al., 1999; Pereira, Miguel Martins, & Saraiva, 2014; 
Salmon, Evert, Song, & Doetsch, 2004), including a previous work at the Department of 
Chemical Sciences and Biomolecules of School of Health of the Polytechnic of Porto.  
On the other hand, to assess the antioxidant properties of vitamin E, and knowing that the 
reference values of α-tocopherol in plasma range from 5.5 mg/L to 17.0 mg/L (MAYO 
CLINIC: Mayo Medical Laboratories, s.d.), the mean value of this range was chosen as 
the intermediate concentration (11,25~11,3 mg/L) to be tested; double (22,5 mg/L) and 
half (5,6 mg/L) concentration values were tested as well, as the upper and lower limit. 
The objective was to assess if a lower concentration of vitamin E would have protective 
effects against H2O2 and if a higher concentration would be more or less effective. 
Vitamin E-only groups (G1, G2 and G3) all showed similar results to their own negative 
controls, which was actually not expected given that vitamin E at low oxidative conditions 
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is described as having a pro-oxidant nature (Bowry & Stocker, 1993; Vargas, Soares, 
Ribeiro, Hebling, & Costa, 2014). 
Contrary to what had been planned, during data analysis, it was noticed that due to an 
experimental design error, the sample size was not a result of 3 individual experiments 
performed in triplicate, but a result of 9 individual experiments. For this reason, and given 
the variability of results, the closest 6 values were chosen for all statistical purposes. 
H2O2 exposure results revealed that cells exposed to H2O2-only conditions presented a 
reduction in cell viability of 80,6% and 79,2% at the concentration of 3 mM and 5 mM, 
respectively. The significant cell death is in line with what has been previously observed 
for these H2O2 concentrations (Madeo et al., 1999; Magherini et al., 2007; Salmon et al., 
2004), even though the results presented here show ~10% less cell death at 3 mM of H2O2 
than previous reports (Magherini et al., 2007). Yeast cell death after 200 min of exposure 
to H2O2 at 3 mM has been explained by the accumulation of high DNA damage (massive 
fragmentation) which would make cell replication impossible (Magherini et al., 2007). 
Evaluation of cell viability with trypan blue and TUNEL assays, as well as electron 
microscopic investigation, were indicative of an apoptotic phenotype (Madeo et al., 1999; 
Magherini et al., 2007), with chromatin condensation being visible after just 30 min of 
H2O2 exposure (Madeo et al., 1999). Moreover, the concomitant decrease in the 
abundance of peroxiredoxin and GST (I), in a previous report, suggests that H2O2 
treatment decreases the expression of these enzymes (or increases their degradation), 
leading the yeast cells to a diminished antioxidant defense, ultimately making them more 
prone to apoptosis (Magherini et al., 2007). The apoptotic phenotype is also described for 
cells incubated with 5 mM H2O2, while necrotic cell death seems to occur at higher 
concentrations (>15 mM) (Madeo et al., 1999).  
On the other hand, in cells cultured with both H2O2 and vitamin E, it is possible to observe 
a tendency of cell viability recovery, which shows vitamin E antioxidant nature. At the 
lower concentration of H2O2 (3 mM), vitamin E seems to have a clear cell-protective 
effect, both at the intermediate (11,3mg/L) and at the highest (22,5mg/L) concentrations, 
with final percentages of cell viability of 115,1% (G6) and 50,0% (G7). This seems to 
suggest that vitamin E was able to counteract the effects of oxidative stress caused by the 
addition of H2O2 to the culture medium. In addition, since with the lower concentration 
of H2O2 and intermediate concentration of vitamin E (G6), the percentage of cell viability 
is higher than that of its control, it is possible that vitamin E not only prevented the toxic 
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effects of exogenously applied H2O2 but also counteracted the effects of other naturally 
present oxidants. Even though the viability results obtained for G6 were not observed for 
G7 - the group with the highest concentration of vitamin E combined with the lower 
concentration of H2O2 - an increase in cell viability, comparatively to the 3 mM H2O2 
group (G5), was still observed (P<0,05). Moreover, the results from both groups with 
concentrations of vitamin E of 11,3 mg/L and 22,5 mg/L combined with 3 mM of H2O2 
(G6 and G7, respectively), differed significantly from each other (P<0,05). This 
discrepancy might be explained by the oxidative role of vitamin E at relatively low 
oxidative conditions, which has been demonstrated in several studies (Bowry & Stocker, 
1993; Kontush & Schekatolina, 2004). It might be the case that 22,5 mg/L of vitamin E 
is a much higher concentration than needed to counteract the toxic effects of H2O2 on 
cells at a concentration of 3 mM. It is possible that part of the vitamin added to the 
medium did not “find” a lipid peroxyl radical to react with and neutralize, thus initiating 
a new lipid peroxidation chain by reacting with a new PUFA (Bowry & Stocker, 1993). 
Nonetheless, in our results, the pro-oxidant action of vitamin E at relatively low oxidative 
conditions does not seem to be enough to aggravate cells oxidative stress, at least during 
the time of the experiments. In fact, the final cell viability percentage of 50,0% (G7) 
differed significantly from 19,4%, the final cell viability percentage of the 3 mM H2O2 
group (G5). Results from this group (G5), however, did not differed from G6, the group 
with the lowest concentration of both vitamin E and H2O2, (except for T=135), which 
could indicate that the concentration of vitamin E added to the media was not enough to 
mitigate the effects of H2O2, even though a slight increase on cell viability throughout the 
180 min of experiment is observable.  
In regards to the 5 mM H2O2 groups, there seems to be a tendency towards cell viability 
increase proportional to the increase in vitamin E concentrations; therefore, the best 
results were achieved with the highest vitamin E concentration, 22,5 mg/L (G11). In fact, 
this group results did not differ from its own control group (P>0,05), indicating a reversal 
of oxidative stress effects. Overall, the recovery rates obtained with vitamin E at 5 mM 
H2O2 conditions were higher than those obtained for 3 mM H2O2, which is in line with 
the dual nature of α-tocopherol but does not correlate well with the absence of significant 
differences on cell viability between both H2O2 concentrations. 
It is, however, not clear whether the effect of the exogenously applied H2O2 and of 
vitamin E as an antioxidant, adequately mimic the environment experienced by S. 
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cerevisiae under normal conditions, or even if it resembles in some way the environment 
inside an organism, as would be the case of neurons. It is hypothesized that given the slow 
rate of α-tocopherol movement between bilayer leaflets, and in the absence of an active 
uptake mechanism, exogenously applied α-tocopherol would take very long to interact 
with intracellular reactive species, primarily reaching the outer leaflet of cell membranes 
(Atkinson et al., 2008). Therefore, and because in the experiments performed for this 
work α-tocopherol and H2O2 were applied simultaneously, it could mean that α-
tocopherol reacted, mainly, with exogenous ROS, preventing their toxic effects.  
The 3-NT and GSH:GSSG quantification results, obtained by HPLC, were not elucidative 
given both the poor sample size and incomplete yeast cell wall disruption.  It is also worth 
mentioning that the common approach for 3-NT quantification in biological samples is 
the previous cleavage of peptide bonds to release the free aminoacids from proteins, in 
tissues or fluids (Teixeira et al., 2016); usually trifluoroacetic acid (TFA) is used to 
promote acid hydrolysis in S. cerevisiae, however, TFA has a strong UV-absorption band, 
which can lead to HPLC baseline fluctuations that disturb high-sensitivity measurements 
(Choikhet, Glatz, & Rozing, 2003). Moreover, nitration of Tyr residues might occur 
during the application of this technique, due to the acid conditions and to the presence of 
nitrite in the sample (Marrocco et al., 2017). Therefore, the use of TFA was not an option 
during the current work. However, despite knowing that 3-NT levels are generally 
increased under conditions of oxidative stress, as previously mentioned, the maintenance 
of 3-NT levels was also expected given that Sies et al., found GPx to rapidly reduce 
ONOO‒ to nitrite, thus protecting against formation of 3-NT (Sies, Sharov, Klotz, 
Briviba, & Du, 1997). The results obtained with this work, particularly at the 5 mM H2O2 
conditions, seem, nonetheless, in line with this report.  
Alongside oxidative stress, an increase in GSH:GSSG ratio would be expected for both 3 
mM and 5 mM of H2O2 conditions. Previous studies have reported a significant increase 
in GPx activity along with a significant increase in the ratio of GSH:GSSG in WT S. 
cerevisiae cells exposed to 5 mM H2O2 for 1h. The faster decrease of free [GSSG] 
comparatively to free [GSH], suggests that GSSG was being rapidly reduced by 
glutathione reductase in response to H2O2; in fact a difference of eightfold in [GSSG] is 
observed between treated and untreated conditions (Paumi, Pickin, Jarrar, Herren, & 
Cowley, 2012). Moreover, Madeo at el., also found GSH levels to be decreased (~20%) 
in WT S. cerevisiae incubated for 200 min with 3 mM H2O2 (Madeo et al., 1999), which 
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is in line with the GSH results for 5 mM H2O2 (Paumi et al., 2012). Therefore, a decrease 
in GSH accompanied by an accentuated decrease in GSSG, should be expected, resulting 
in an increased ratio of GSH:GSSG. In this context, and accounting for its antioxidant 
potential, the addition of vitamin E could hypothetically lead to a smaller GSH:GSSG 
increase. Alternatively, because α-tocopheroxyl radicals also depend on GSH for their 
recycling, it could be that the highest concentration of vitamin E (22,5 mg/L) would 
actually accentuate the decrease of [GSH].  
Thereby, and although no conclusions can be drawn from the redox biomarkers results, 
given their inconsistency and poor sample size, the cell viability experiments 
demonstrated, overall, the toxic effects of H2O2 and the antioxidant potential of α-
tocopherol, mainly under the condition of H2O2 at 5 mM. In general, a larger sample size 
and better disruption methods were needed for more reliable results and conclusions. 
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Our results reinforce the already described toxic effects of H2O2 as an oxidative stress 
inducer, as well as the antioxidant properties of vitamin E. For the concentration of 3 mM 
H2O2, it was found that 11,25 mg/L vitamin E was able to prevent the toxic effects of 
H2O2. As for the higher concentration of H2O2, 5 mM, it was found that 22,5 mg/L was 
the one capable of reversing oxidative stress to a greater level, with 41,3% of recovery. 
A tendency of increased cell viability with increasing concentrations of vitamin E is also 
noticeable, mostly at 5 mM H2O2 conditions. 
Considering the detrimental effects of oxidative stress in neurodegenerative disorders, the 
modulation of ROS levels with the supplementation of antioxidants, such as vitamin E, 
could represent a treatment option to slow down neurodegeneration and reduce associated 
symptoms, preferentially at early disease stages or as a form of prevention.  
Overall, we consider the results from this study to be preliminary and in need of much 
further investigation, so that more concise and reliable results can be obtained and its 
insights possibly extrapolated for neurodegeneration therapeutic options. 
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In the near future we will be analysing the levels of 3-NT and GSH:GSSG of all S. 
cerevisiae samples collected during this work, in order to increase sample size reach 
consistency of results.  
The investigation of cell viability under lower and higher concentrations of vitamin E 
would also be interesting in order to comprehend what happens at the concentration limits 
and whether or not reversion can occur.  
An interesting approach would also be to re-do these experiments with both vitamin E 
and vitamin C, given the beneficial results on oxidative stress reported on clinical trial 
patients and in vitro experiments.  
In the future, we also aim to test vitamin E antioxidant potential using a neurodegenerative 
disease yeast model to study and compare the cellular response between a normal 
situation and a pathological one.   
In view of this, it is also our goal to assess the influence of oxidative stress on 
neurotransmitters, such as GABA and glutamate, as well as to attempt modulation of 
neurotransmitters levels with vitamin E. 
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